Literature DB >> 34188939

Case report: a rare case of NOMA (cancrum oris) in a Malian woman.

H Traore1, E Sogodogo2, A Coulibaly1, A Toure1, S Thiocary1, M D Sidibé1, L G Timbiné2, A K Sangaré2, B Y Traoré2, J Ouedraogo2, D Sogodogo3, B Kouriba2.   

Abstract

Noma or cancrum oris is a multi-bacterial and opportunistic infection that destroys soft tissue, as well as muscle and bone, and can be fatal. We present a rare case of Noma in a 32-year-old Malian woman, from whom we isolated an Escherichia coli extended-spectrum beta-lactamase.
© 2021 The Author(s).

Entities:  

Keywords:  Antibiotic; Escherichia coli; Mali; Noma; cancrum oris

Year:  2021        PMID: 34188939      PMCID: PMC8219893          DOI: 10.1016/j.nmni.2021.100907

Source DB:  PubMed          Journal:  New Microbes New Infect        ISSN: 2052-2975


Case Presentation

A 32-year-old housewife with no known pathological history was admitted to the stomatology and maxillofacial surgery department of the National Centre of Odonto-Stomatology of Bamako. The patient was referred from a rural health centre. The onset of symptoms would go back 16 days before admission marked by pain and swelling of the left cheek, in a context of hyperthermia and lack of appetite. The patient had undergone traditional treatment based on herbal decoctions. The consultation in the health centre near the place of residence of the patient was motivated by the presence of a black border delimiting the future loss of substance and gangrene with a foul odour. She received treatment with antibiotics consisting of Metronidazole, ciprofloxacin, and gentamicin. On admission to the hospital, a clinical examination was performed. A loss of substance involving the left cheek was revealed on exo-oral examination. The wound was rounded, measuring 6 × 4 cm, and resulting in an orostoma through which denudation of the mandibular bone was visible (Fig. 1). Laboratory investigations included a haemoglobin concentration of 7 g/dl, hyperleukocytosis and negative HIV serology. Noma in adults and the elderly has often been associated with immunosuppression [1,2]. A sterile swab was used to collect pus from the ulcer and discharged in a transport medium preserving methanogen and anaerobic bacteria viability [3]. This transport medium consisted of (per litre) KCl 0.2 g, CaCl2 0.1 g, MgCl2 0.1 g, KH2PO4 0.2 g, Na2HPO4 1.15 g, NaCl 3 g, ascorbic acid 1 g, uric acid 0.1 g, and glutathione 0.1 g [3].
Fig. 1

Physical sequelae of NOMA in a 32-year-old woman.

Physical sequelae of NOMA in a 32-year-old woman. The sample collected from the ulcer was cultured on different agar plates: Columbia agar with 5% sheep blood:non-selective agar (BioMerieux, Craponne, France), Drigalski agar (Gram-negative selective agar), and Columbia and colistin plus nalidixic acid agar:Gram-positive selective agar (BioMerieux, Craponne, France), for aerobic bacteria; chocolate agar with IsoVitaleX (BioMerieux, Craponne, France) under microaerophilic conditions (5% CO2) for difficult microorganisms; Schaedler agar (BioMerieux, Craponne, France), with added kanamycin plus vancomycin under anaerobic conditions for anaerobic microorganisms and Can 2 agar: selective yeast medium (BioMerieux, Craponne, France). Colonies of bacteria and fungi were subjected to phenotypic testing using the automated Vitek 2 system and software. The bacteria were then reidentified by matrix-assisted laser desorption-ionisation time-of-flight mass spectrometry using a Microflex spectrometer (Bruker Daltonics, Bremen, Germany). After analysis, we found a polymicrobial infection. Among these bacteria, we have isolated an Escherichia coli extended-spectrum beta-lactamase (ESBL). Double-disk synergy methods were used for detection of ESBL-producing strains. We observed a zone of inhibition enhanced by the action of two cephalosporin discs, Ceftriaxone and cefepime on the side facing amoxicillin + clavulanic acid was considered to produce ESBL (Fig. 2).
Fig. 2

Isolation of Extended-Spectrum β-lactamase (ESBL) producing Escherichia coli. The formation of a zone of inhibition between the three antibiotics is observed. AMC: amoxicillin/acid clavulanic; FEP: Cefepime, CRO: ceftriaxone.

Isolation of Extended-Spectrum β-lactamase (ESBL) producing Escherichia coli. The formation of a zone of inhibition between the three antibiotics is observed. AMC: amoxicillin/acid clavulanic; FEP: Cefepime, CRO: ceftriaxone. A study carried out in Mali in 2016 showed that nearly two-thirds (61.8%) of Enterobacteriaceae isolated from blood cultures were producers of ESBLs, including 27.5% of Escherichia coli [4]. Another recent study in Mali showed ESBL production rates of 24.81% in Escherichia coli [5]. In vitro susceptibility was assessed using the Vitek 2 antibiotic susceptibility testing card and by diffusion of antibiotic discs on Mueller Hinton agar. The zones of inhibition on Mueller Hinton agar were read by Scan 4000. The results showed susceptibility to Imipenem, ertapenem, Colistin, Gentamicin, amikacin, nitrofurantoin, Piperacillin/Tazobactam, and fosfomycin (Table 1). Anaerobic cultures have remained sterile, although studies have shown, in most cases, the presence of Prevotella intermedia and Fusobacterium necrophorum, which are strictly anaerobic [6,7]. The microorganisms found in Noma are predominantly anaerobic, most of which are part of the normal oral microbiota [8]. Studies also have soil bacteria typical of gangrene, of animal origin that could greatly contribute to the infection [8]. The other isolated microorganisms are composed of Kluyveromyces lactis, Candida tropicalis, Clavispora lusitaniae, and Paenibacillus alvei. The patient was already on antibiotic therapy before the microbiological analysis. The recovery of the patient with sequelae occurred after 10 days of hospitalisation. She had benefited from intense renutrition and 5 days of medical treatment consisting of three drugs: amoxicillin/clavulanic acid at a dose of 3 g/day, metronidazole 1.5 g/day, paracetamol 3 g/day, and treatment of parasitic diseases with albendazole 400 mg/day for 3 days. Sequestrectomy and local care helped heal the wounds. A follow-up of the nutritional state and a rehabilitation to prevent the installation of a permanent constriction of the jawbones are underway with a view to the future repair of the sequelae. The patient died a month later in her locality outside the hospital. The socio-economic factors of the patient did not allow her to benefit from a good follow-up of the sequelae of Noma. A study carried out in Mali in 2019 showed that a total of 348 antibiotics were prescribed in 204 patients in the internal medicine department of the University Hospital Hospital of “Point G” [9]. Among which 295 antibiotics have been prescribed as part of probabilistic antibiotic therapy. This study found that the most prescribed probabilistic antibiotics were amoxicillin + Clavulanic acid (38.6%), metronidazole (12.6%) and ceftriaxone (10.2%).
Table 1

Antimicrobial susceptibilities of Escherichia coli isolate obtained from a 32-year-old woman

AntibioticsResults
ImipenemSensitive
ErtapenemSensitive
ColistinSensitive
FosfomycinSensitive
GentamycinSensitive
AmikacinSensitive
NitrofurantoinSensitive
Pipéracilline/TazobactamSensitive
Amoxicillin-clavulanic acidIntermediate
CefepimeIntermediate
AmoxicillinResistant
Trimethoprim-sulfamethoxazoleResistant
CeftriaxoneResistant
DoxycyclineResistant
CefalotineResistant
CiprofloxacinResistant
Antimicrobial susceptibilities of Escherichia coli isolate obtained from a 32-year-old woman The emergence and dissemination of broad-spectrum beta-lactamases in Mali are linked to the use of broad-spectrum antibiotics both in hospitals and in self-medication.

Transparency declaration

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this article.
  6 in total

1.  Prevalence of ESBL-producing Enterobacteriaceae isolated from blood cultures in Mali.

Authors:  Samba Adama Sangare; Almoustapha Issiaka Maiga; Ibrehima Guindo; Aminata Maiga; Namory Camara; Oumar Agaly Dicko; Souleymane Diallo; Flabou Bougoudogo; Laurence Armand-Lefevre; Antoine Andremont; Ibrahim Izetiegouma Maiga
Journal:  J Infect Dev Ctries       Date:  2016-10-31       Impact factor: 0.968

Review 2.  Noma (cancrum oris).

Authors:  Cyril O Enwonwu; William A Falkler; Reshma S Phillips
Journal:  Lancet       Date:  2006-07-08       Impact factor: 79.321

3.  Noma (cancrum oris): a report of a case in a young AIDS patient with a review of the pathogenesis.

Authors:  J N Masipa; A M Baloyi; R A G Khammissa; M Altini; J Lemmer; L Feller
Journal:  Head Neck Pathol       Date:  2012-08-21

4.  Pattern of noma (cancrum oris) and its risk factors in Northwestern Nigeria: A hospital-based retrospective study.

Authors:  Semiu Adetunji Adeniyi; Kehinde Joseph Awosan
Journal:  Ann Afr Med       Date:  2019 Jan-Mar

5.  A versatile medium for cultivating methanogenic archaea.

Authors:  Saber Khelaifia; Didier Raoult; Michel Drancourt
Journal:  PLoS One       Date:  2013-04-17       Impact factor: 3.240

Review 6.  A Review on Noma: A Recent Update.

Authors:  Nipun Ashok; Bassel Tarakji; Shourouk Darwish; Jean C Rodrigues; Mohammad A Altamimi
Journal:  Glob J Health Sci       Date:  2015-07-30
  6 in total
  1 in total

Review 1.  Noma (cancrum oris): A scoping literature review of a neglected disease (1843 to 2021).

Authors:  Elise Farley; Ushma Mehta; M Leila Srour; Annick Lenglet
Journal:  PLoS Negl Trop Dis       Date:  2021-12-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.